AirSculpt Technologies' Q4 revenue misses analyst expectations as same-store sales dip
Overview
US body contouring provider's preliminary Q4 revenue missed analyst expectations
Fiscal 2025 preliminary revenue was $151.8 mln, with same-store revenue down single digits in December
Company saw positive comparable sales in February 2026 after refreshed marketing strategy
Outlook
AirSculpt expects Q1 2026 revenue of $38.5-$39.5 mln with same-store revenue approximately flat
Result Drivers
MARKETING STRATEGY - Co said refreshed marketing strategy contributed to positive same-store sales in February 2026 and improved demand trends at year end
EXPANDED PROCEDURE OFFERINGS - Expansion into adjacent procedures cited as a factor in improved demand and sales trend
OPERATIONAL TIGHTENING - Tightening operations contributed to improved sales trend at year end, according to CEO
Company press release: ID:nGNX6pD2jw
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Miss | $33.40 mln | $34.51 mln (3 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for AirSculpt Technologies Inc is $6.50, about 251.4% above its March 13 closing price of $1.85
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
